The Behavioral Health Outcomes Consortium released a standardized framework Oct. 6 aimed at creating a consistent approach to ...

The FDA is gathering public feedback as it considers how early-phase clinical trials of ibogaine drug products should be ...

Fentanyl is no longer the only substance keeping addiction clinicians up at night. Some of the newest threats are being sold ...

Poison control centers are raising concerns about products sold as cat’s claw after testing found some contained ...